Author: dld5dt@virginia.edu

NIH – Immune Cell Engineering For Targeted Therapy And Disease Monitoring in Type 1 Diabetes (R01 Clinical Trial Not Allowed)

Purpose: This initiative will support the engineering of immune cells to target the human pancreatic compartment to report on previously inaccessible information about diabetes initiation and progression, and/or to deliver…

The State of Science: Conversations with Holden Thorp

The State of Science: Conversations with Holden Thorp is a virtual speaker series taking place over three Mondays in late February and early March. The hour-long sessions will feature informal discussions…

NIH – High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 – Clinical Trials Not Allowed)

Purpose: This FOA will support high-throughput screening approaches to identify novel receptors, signal transducers, or small molecules that modulate Substance Use Disorder (SUD)-relevant signal transduction pathways (dopamine, opioid, cannabinoid, nicotinic,…

NIH – Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 – Clinical Trial Not Allowed)

Purpose: The purpose of this FOA is to support exploratory studies developing or using novel tools or technologies or testing novel hypotheses to investigate mechanistic questions in HIV infection, replication,…

NIH – SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)

Purpose: This Funding Opportunity Announcement (FOA) will support research grants to address urgent, time-sensitive research questions on the relationships between alcohol consumption and COVID-19 related outcomes and consequences. The principal…

NIH – The Cellular Scale Connectome in Aging and Alzheimer’s Disease (U01 Clinical Trial Not Allowed)

Purpose: This Funding Opportunity Announcement (FOA) invites applications that will: (1) promote the development of a comprehensive characterization of brain circuits susceptible to Alzheimer’s disease type pathology and/or neurodegeneration in…

2021 JOHN F. ANDERSON DISTINGUISHED LECTURE

On Monday, 22 March 2021 Dr. Richard Henderson, awarded the 2017 Nobel Prize in Chemistry, will speak on the Cryo-EM Revolution in Structural Biology. The flyer and online link to…

NIH – Notice of Special Interest (NOSI) on Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities

Purpose: This Notice of Special Interest (NOSI) highlights the need for research strategies and interventions to address vaccine hesitancy, uptake, and implementation among populations who experience health disparities in the…

NIH – Nutrition for Precision Health Program

Purpose: The National Institutes of Health (NIH) has published six Funding Opportunity Announcements (FOAs) associated with its new Common Fund program, Nutrition for Precision Health, powered by the All of…

NIH – Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional)

Purpose: This Funding Opportunity Announcement (FOA) invites researchers to submit applications for multi-disciplinary diagnostic strategies for rare diseases that combine machine-assistance, genomic analysis, and clinical consultation. Of particular importance, these…